Vroman Ken
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Vroman Ken. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| CME | Chief Transformation Officer | Tax Withholding | 971 | $258.83 | $251,324 | Sep 16, 2025 |
| CME | Chief Transformation Officer | Tax Withholding | 1,625 | $258.68 | $420,355 | Mar 15, 2025 |
| CME | Chief Transformation Officer | Sale | 5,066 | $250.00 | $1,266,500 | Feb 13, 2025 |
| CME | Chief Transformation Officer | Award / Grant | 3,088 | $218.53 | $674,821 | Sep 15, 2024 |
| CME | Chief Transformation Officer | Award / Grant | 5,292 | $217.50 | $1,151,010 | Mar 15, 2024 |
| CME | Chief Transformation Officer | Tax Withholding | 105 | $206.82 | $21,716 | Sep 15, 2023 |
| CME | Chief Transformation Officer | Tax Withholding | 108 | $187.21 | $20,219 | Mar 16, 2023 |
| CME | Chief Transformation Officer | Award / Grant | 3,540 | — | — | Sep 15, 2022 |
| CME | Chief Transformation Officer | Tax Withholding | 142 | — | — | Sep 14, 2022 |
| CME | Chief Transformation Officer | Tax Withholding | 142 | $191.30 | $27,165 | Sep 14, 2022 |
| CME | Chief Transformation Officer | Sale | 750 | $201.41 | $151,058 | Sep 12, 2022 |
| CME | Chief Transformation Officer | Tax Withholding | 73 | $242.01 | $17,667 | Mar 15, 2022 |
| CME | Sr MD International & Optimiza | Sale | 445 | $220.00 | $97,900 | Nov 9, 2021 |
| CME | Sr MD International & Optimiza | Tax Withholding | 117 | $188.69 | $22,077 | Sep 16, 2021 |
| CME | Sr MD International & Optimiza | Tax Withholding | 125 | $188.96 | $23,620 | Sep 15, 2021 |
| CME | Sr MD International & Optimiza | Tax Withholding | 78 | $207.12 | $16,155 | Mar 15, 2021 |
| CME | Sr MD International & Optimiza | Sale | 4,541 | $152.63 | $693,093 | Nov 2, 2020 |
| CME | Sr MD International & Optimiza | Tax Withholding | 121 | $170.20 | $20,594 | Sep 15, 2020 |
| CME | Sr MD International & Optimiza | Tax Withholding | 202 | $168.10 | $33,956 | Sep 15, 2020 |
| CME | Sr MD International & Optimiza | Award / Grant | 960 | — | — | Mar 16, 2020 |
| CME | Sr MD Commodities Prod & Svcs | Award / Grant | 3,048 | — | — | Sep 15, 2013 |
| CME | Sr MD Comm & Info Prod & Svcs | Tax Withholding | 70 | $74.29 | $5,200 | Jun 16, 2013 |
| CME | Sr MD Comm & Info Prod & Svcs | Tax Withholding | 133 | $63.14 | $8,398 | Mar 15, 2013 |
| CME | Sr MD Comm & Info Prod & Svcs | Sale | 1,492 | $62.69 | $93,533 | Mar 12, 2013 |
| CME | Sr MD Comm & Info Prod & Svcs | Award / Grant | 1,664 | — | — | Mar 8, 2013 |
| CME | Sr MD Comm & Info Prod & Svcs | Award / Grant | 3,716 | — | — | Sep 15, 2012 |
| CME | Sr MD Comm & Info Prod & Svcs | Tax Withholding | 14 | $277.91 | $3,891 | Jun 16, 2012 |
| CME | MD OTC Svcs & Comm & Info Prod | Award / Grant | 864 | — | — | Sep 15, 2011 |
| CME | MD OTC Svcs & Comm & Info Prod | Tax Withholding | 53 | $271.49 | $14,389 | Sep 15, 2010 |
| CME | MD & Chief Corp Dev Officer | Award / Grant | 708 | — | — | Sep 15, 2009 |
| CME | MD & Chief Corp Dev Officer | Award / Grant | 215 | — | — | Jun 16, 2008 |